Compare ADVB & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADVB | CRMT |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | Hong Kong | United States |
| Employees | N/A | 1500 |
| Industry | Medical Specialities | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 7.9M |
| IPO Year | 2023 | 2026 |
| Metric | ADVB | CRMT |
|---|---|---|
| Price | $3.22 | $0.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 32.1K | ★ 639.0K |
| Earning Date | 10-13-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3431.25 | N/A |
| EPS | ★ 5.33 | N/A |
| Revenue | $127,637.00 | ★ $1,281,502,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.29 |
| P/E Ratio | $0.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.15 | $0.57 |
| 52 Week High | $113.80 | $28.70 |
| Indicator | ADVB | CRMT |
|---|---|---|
| Relative Strength Index (RSI) | 21.55 | 36.18 |
| Support Level | N/A | N/A |
| Resistance Level | $5.59 | $1.49 |
| Average True Range (ATR) | 0.55 | 0.23 |
| MACD | -0.16 | -0.00 |
| Stochastic Oscillator | 5.01 | 22.71 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
America's Car-Mart Inc is one of the publicly held automotive retailers in the United States focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The Company mainly sells older model used vehicles and provides financing for substantially all of its customers. The company operates in the Integrated Auto Sales and Finance segment of the used car market. In this industry, the nature of the sale and the financing of the transaction, financing processes, the type of customer and the methods used to distribute the company's products and services, including the actual servicing of the contracts as well as the regulatory environment in which the company operates, all have similar characteristics. The company operates in a single reportable segment.